Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LGVN | LONGEVERON INC | $22.41M | $0.70 | $80.00 | 11,279.80% | Buy | 2 | 262.75% | N/A | -62.53% | -42.00% | |||
| VNRX | VOLITIONRX LTD | $4.63M | $0.34 | $12.00 | 3,439.82% | Buy | 3 | 122.46% | N/A | -25.97% | 100.63% | |||
| CNSY | CERENOME INC | $22.92M | $3.02 | $66.00 | 2,085.43% | Strong Buy | 2 | 118.07% | N/A | 330.88% | 128.84% | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $13.32M | $0.41 | $8.50 | 1,978.24% | Strong Buy | 2 | N/A | N/A | -6,492.65% | 9,852.66% | |||
| CALC | CALCIMEDICA INC | $20.08M | $0.59 | $9.50 | 1,515.65% | Strong Buy | 2 | N/A | N/A | -931.72% | -263.37% | |||
| CNTX | CONTEXT THERAPEUTICS INC | $38.96M | $0.42 | $6.25 | 1,374.06% | Strong Buy | 4 | N/A | N/A | -116.86% | -96.69% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $24.42M | $0.78 | $11.00 | 1,310.26% | Strong Buy | 2 | 397.07% | N/A | N/A | -69.85% | |||
| ITRG | INTEGRA RESOURCES CORP | $588.57M | $2.91 | $38.92 | 1,237.35% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| GOSS | GOSSAMER BIO INC | $85.06M | $0.17 | $2.06 | 1,081.61% | Buy | 6 | 33.31% | N/A | -103.93% | 127.13% | |||
| EVTL | VERTICAL AEROSPACE LTD | $103.79M | $0.75 | $8.67 | 1,055.60% | Strong Buy | 4 | N/A | N/A | N/A | -69.63% | |||
| IVVD | INVIVYD INC | $265.87M | $0.90 | $10.00 | 1,008.65% | Strong Buy | 2 | 49.53% | N/A | -34.87% | -28.85% | |||
| VVOS | VIVOS THERAPEUTICS INC | $5.11M | $0.25 | $2.80 | 1,002.36% | Buy | 2 | 10.25% | N/A | N/A | -100.72% | |||
| NRXP | NRX PHARMACEUTICALS INC | $149.80M | $3.46 | $34.50 | 897.11% | Strong Buy | 4 | 547.11% | N/A | -142,616.26% | 709.74% | |||
| TENX | TENAX THERAPEUTICS INC | $79.34M | $2.12 | $19.71 | 829.91% | Strong Buy | 8 | N/A | N/A | -26.75% | -24.97% | |||
| KSCP | KNIGHTSCOPE INC | $32.59M | $1.38 | $12.67 | 817.90% | Strong Buy | 3 | 52.93% | N/A | -178.27% | -94.34% | |||
| GUTS | FRACTYL HEALTH INC | $117.32M | $0.74 | $6.67 | 804.61% | Strong Buy | 3 | N/A | N/A | -715.11% | 14.52% | |||
| VERU | VERU INC | $47.74M | $2.80 | $24.50 | 775.00% | Strong Buy | 2 | N/A | N/A | -46.58% | -35.70% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $117.23M | $0.84 | $7.33 | 771.94% | Strong Buy | 3 | 32.49% | N/A | -89.39% | -57.64% | |||
| CTXR | CITIUS PHARMACEUTICALS INC | $15.84M | $0.58 | $5.00 | 766.55% | Strong Buy | 2 | 199.92% | N/A | 25.22% | 11.81% | |||
| DVLT | DATAVAULT AI INC | $277.32M | $0.29 | $2.50 | 756.16% | Strong Buy | 2 | 335.36% | N/A | -7.88% | -7.00% | |||
| OTLK | OUTLOOK THERAPEUTICS INC | $151.67M | $0.62 | $5.20 | 734.67% | Buy | 3 | N/A | N/A | N/A | -113.80% | |||
| OSTX | OS THERAPIES INC | $76.11M | $1.65 | $13.33 | 708.06% | Strong Buy | 3 | N/A | N/A | N/A | -23.77% | |||
| CRVO | CERVOMED INC | $40.07M | $2.65 | $21.20 | 700.00% | Strong Buy | 5 | -100.00% | N/A | -72.54% | -64.08% | |||
| TCRX | TSCAN THERAPEUTICS INC | $52.66M | $0.78 | $6.00 | 672.20% | Buy | 3 | 51.28% | N/A | -62.10% | -25.00% | |||
| BEAT | HEARTBEAM INC | $27.10M | $0.48 | $3.70 | 669.23% | Strong Buy | 5 | N/A | N/A | -112.46% | -86.45% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $26.45M | $2.65 | $20.33 | 667.28% | Strong Buy | 3 | N/A | N/A | -5.69% | -4.73% | |||
| VERI | VERITONE INC | $80.47M | $0.80 | $6.13 | 664.67% | Buy | 4 | 29.93% | N/A | 37.88% | 9.66% | |||
| INTZ | INTRUSION INC | $16.96M | $0.69 | $5.25 | 658.67% | Buy | 2 | 44.83% | N/A | -277.65% | -62.14% | |||
| RNTX | REIN THERAPEUTICS INC | $69.01M | $0.80 | $6.00 | 650.00% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| HUMA | HUMACYTE INC | $189.46M | $0.68 | $5.11 | 648.83% | Strong Buy | 7 | 270.16% | N/A | 181.28% | 41.04% | |||
| CLNN | CLENE INC | $59.75M | $4.65 | $34.00 | 631.18% | Strong Buy | 3 | 865.97% | N/A | -366.29% | 393.89% | |||
| SION | SIONNA THERAPEUTICS INC | $278.96M | $6.17 | $44.80 | 626.09% | Buy | 7 | N/A | N/A | -55.99% | -52.53% | |||
| INUV | INUVO INC | $11.37M | $0.69 | $5.00 | 624.64% | Strong Buy | 2 | -3.74% | N/A | N/A | N/A | |||
| ANVS | ANNOVIS BIO INC | $75.84M | $1.78 | $12.50 | 602.25% | Strong Buy | 2 | N/A | N/A | -1,624.09% | 313.56% | |||
| TARA | PROTARA THERAPEUTICS INC | $231.06M | $3.91 | $27.00 | 590.54% | Strong Buy | 3 | N/A | N/A | 24.01% | 21.99% | |||
| KPTI | KARYOPHARM THERAPEUTICS INC | $44.46M | $1.96 | $13.25 | 576.02% | Strong Buy | 4 | 15.04% | N/A | -6.52% | 19.33% | |||
| OCGN | OCUGEN INC | $478.15M | $1.41 | $9.50 | 573.76% | Strong Buy | 4 | 236.83% | N/A | -717.30% | 95.61% | |||
| ELTX | ELICIO THERAPEUTICS INC | $78.32M | $2.98 | $19.80 | 564.43% | Strong Buy | 6 | N/A | N/A | -1,351.02% | -342.26% | |||
| ENHA | ENHANCED GROUP INC | $624.37M | $1.61 | $10.00 | 521.12% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| CMPX | COMPASS THERAPEUTICS INC | $437.61M | $2.43 | $14.83 | 510.41% | Strong Buy | 6 | N/A | N/A | 42.59% | 37.19% | |||
| BZAI | BLAIZE HOLDINGS INC | $71.84M | $0.50 | $3.00 | 504.84% | Strong Buy | 3 | 97.83% | N/A | -113.93% | -61.31% | |||
| DCGO | DOCGO INC | $39.08M | $0.40 | $2.38 | 501.27% | Strong Buy | 4 | 6.00% | N/A | -9.32% | -5.94% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.